'Pharma industry grappling with pricing, regulatory issues'
The buoyant pharmaceutical industry is still struggling to deal with the challenges around pricing in the domestic market, increased regulations as well as data integrity, says an EY survey.
Jun 03, 2015, 21:12 PM IST